# Brazil clinical research regulatory and sectoral development

> Developing situation record from CLSTR: https://clstr.news/situations/brazil-clinical-research-regulatory-development
> Updated: 2026-11-19T23:00:00.000Z. Sources: 6. Developments: 4.

Brazil has seen an increase in global clinical research participation following the implementation of Law 14.874, the Clinical Research Law. Sanctioned in May 2024 and regulated in October 2025, this legislation established the first dedicated legal framework for the sector, creating the National System of Ethics in Research Involving Humans and shortening analysis timelines for ethical opinions.

To support this framework, the Brazilian Ministry of Health launched the National Registry of Clinical Research Centers (CNCPC). Coordinated by the Clinical Research Unit of the Botucatu Medical School at Unesp, the project is supported by R$ 4.5 million from the Ministry of Health and CNPq. The registry aims to map the infrastructure, specialized teams, and expertise of public and private centers, including hospitals, universities, and diagnostic laboratories. Fernanda De Negri, secretary of the Secretariat of Science, Technology, and Innovation in Health (SCTIE), stated the mapping is intended to identify scientific potential, increase transparency, and reduce regional inequalities to better align research with the needs of the Unified Health System (SUS).

A census by Sindusfarma and Datafolha shows oncology is the primary focus of pharmaceutical clinical studies in Brazil at 17.8%, followed by metabolic and endocrine diseases (15%), autoimmune and inflammatory diseases (14.9%), and the central nervous system (13.7%). Looking ahead, 65% of companies intend to increase research investments, with oncology remaining the top priority for 26% of firms.

In Brasília, the Ministry of Health recently hosted international forums focused on strengthening clinical research, genomic knowledge, and precision public health. Strategic initiatives discussed include the regulation of human research, the creation of the National Ethics in Research Instance (Inaep), and the development of a national genomic database.

## Timeline

### 2026-11-19: Brazil hosts international forums on clinical research and precision health

Brazil held international forums in Brasília to advance clinical research and precision health, while regional discussions in Mato Grosso do Sul addressed ongoing vaccination challenges.

2 sources. https://clstr.news/cluster/brazil-hosts-international-forums-on-clinical-research-and-precision-health

### 2026-11-11: Oncology leads pharmaceutical clinical research in Brazil

A new census shows oncology leads pharmaceutical clinical research in Brazil, while the Ministry of Health develops a national registry to map research centers and support SUS drug development.

2 sources. https://clstr.news/cluster/oncology-leads-pharmaceutical-clinical-research-in-brazil

### 2026-11-03: Brazil Ministry of Health launches national clinical research center registry

Brazil is establishing a National Registry of Clinical Research Centers to map public and private research infrastructure, aiming to strengthen scientific innovation and public health policy.

2 sources. https://clstr.news/cluster/brazil-ministry-of-health-launches-national-clinical-research-center-registry

### 2026-10-15: Brazil clinical research participation rises under new legal framework

Brazil's clinical research ranking rose from 18th to 12th following the implementation of Law 14.874, with annual investments expected to exceed R$ 2 billion.

8 sources. https://clstr.news/cluster/brazil-clinical-research-participation-rises-under-new-legal-framework

---
Cite as: Brazil clinical research regulatory and sectoral development. CLSTR, https://clstr.news/situations/brazil-clinical-research-regulatory-development
